ICU Medical, Inc. $ICUI Shares Acquired by Raymond James Financial Inc.

Key Points

• Raymond James Financial Inc. increased its stake in ICU Medical, Inc. by 7.5% in the first quarter, holding 69,297 shares valued at approximately $9.6 million.
• Several institutional investors have significantly raised their stakes in ICU Medical, with notable increases from Citigroup Inc. (220.7%) and Invesco Ltd. (80.1%).
• ICU Medical reported quarterly earnings of $2.10 per share, exceeding expectations and setting a fiscal year 2025 guidance of $6.85 to $7.15 EPS.

Raymond James Financial Inc. raised its position in shares of ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 7.5% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 69,297 shares of the medical instruments supplier's stock after buying an additional 4,833 shares during the quarter. Raymond James Financial Inc. owned about 0.28% of ICU Medical worth $9,623,000 at the end of the most recent reporting period.

Several other hedge funds have also modified their holdings of ICUI. Quarry LP lifted its position in shares of ICU Medical by 764.3% during the fourth quarter. Quarry LP now owns 242 shares of the medical instruments supplier's stock valued at $38,000 after buying an additional 214 shares during the last quarter. GAMMA Investing LLC lifted its position in shares of ICU Medical by 27.2% during the first quarter. GAMMA Investing LLC now owns 716 shares of the medical instruments supplier's stock valued at $99,000 after buying an additional 153 shares during the last quarter. Blue Trust Inc. lifted its position in shares of ICU Medical by 23.0% during the first quarter. Blue Trust Inc. now owns 801 shares of the medical instruments supplier's stock valued at $111,000 after buying an additional 150 shares during the last quarter. Tower Research Capital LLC TRC lifted its position in shares of ICU Medical by 87.8% during the fourth quarter. Tower Research Capital LLC TRC now owns 1,352 shares of the medical instruments supplier's stock valued at $210,000 after buying an additional 632 shares during the last quarter. Finally, Vontobel Holding Ltd. purchased a new stake in shares of ICU Medical during the first quarter valued at about $235,000. 96.10% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at ICU Medical

In other ICU Medical news, CEO Vivek Jain purchased 21,929 shares of the business's stock in a transaction that occurred on Thursday, August 14th. The shares were bought at an average price of $112.84 per share, for a total transaction of $2,474,468.36. Following the acquisition, the chief executive officer owned 130,149 shares in the company, valued at $14,686,013.16. This represents a 20.26% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director David C. Greenberg purchased 1,200 shares of the business's stock in a transaction that occurred on Wednesday, August 27th. The stock was acquired at an average price of $126.42 per share, for a total transaction of $151,704.00. Following the acquisition, the director owned 7,960 shares in the company, valued at $1,006,303.20. This trade represents a 17.75% increase in their position. The disclosure for this purchase can be found here. 1.50% of the stock is currently owned by corporate insiders.

ICU Medical Stock Performance

Shares of ICU Medical stock traded up $5.61 during midday trading on Friday, hitting $131.24. The company had a trading volume of 280,702 shares, compared to its average volume of 376,226. The stock has a market cap of $3.24 billion, a price-to-earnings ratio of -86.34 and a beta of 0.86. The company has a quick ratio of 1.17, a current ratio of 2.44 and a debt-to-equity ratio of 0.63. The company has a fifty day simple moving average of $126.51 and a 200 day simple moving average of $134.81. ICU Medical, Inc. has a 12-month low of $107.00 and a 12-month high of $196.26.

ICU Medical (NASDAQ:ICUI - Get Free Report) last announced its quarterly earnings data on Thursday, August 7th. The medical instruments supplier reported $2.10 EPS for the quarter, beating the consensus estimate of $1.44 by $0.66. ICU Medical had a negative net margin of 1.56% and a positive return on equity of 7.24%. The firm had revenue of $543.57 million during the quarter, compared to analyst estimates of $543.33 million. During the same period last year, the firm posted $1.56 EPS. ICU Medical's revenue was down 8.0% on a year-over-year basis. ICU Medical has set its FY 2025 guidance at 6.850-7.15 EPS. As a group, analysts predict that ICU Medical, Inc. will post 4.11 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several analysts have commented on ICUI shares. Wall Street Zen raised shares of ICU Medical from a "hold" rating to a "buy" rating in a research report on Friday. Piper Sandler started coverage on shares of ICU Medical in a research report on Friday, August 15th. They issued an "overweight" rating and a $145.00 price objective for the company. Finally, Raymond James Financial decreased their price objective on shares of ICU Medical from $187.00 to $180.00 and set a "strong-buy" rating for the company in a research report on Friday, August 8th. One investment analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and one has given a Hold rating to the company. According to MarketBeat.com, the company has a consensus rating of "Buy" and an average price target of $179.00.

ICU Medical Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.